ERBB2 and breast cancer: Among the three breast cancer subtypes, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+), and triple-negative subtypes, the HR+ subtype comprises about 70% of all breast cancers [2].